Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile
BackgroundOmalizumab is the first biological therapy used to treat moderate-to-severe asthma and certainly the one with the highest number of publications.MethodsA systematic review and meta-analysis were performed to examine two critical outcomes of omalizumab therapy, asthma exacerbation rate, the...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2023-03-01
|
| Ráidu: | Frontiers in Pediatrics |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fped.2022.1033511/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|